All posts by: Michael Zand

About Michael Zand

CAR T-Cell Therapy Effective for Children With ALL, Updated Study Results Show – AJMC.com Managed Markets Network

Continue reading

2018-02-01 NEWS

CAR T-Cell Therapy Effective for Children With ALL, Updated Study Results Show
AJMC.com Managed Markets Network
Final updated results of the pivotal phase 2 study that led to last year’s FDA approval of the first chimeric antigen receptor (CAR) T-cell therapy were published Wednesday in the New England Journal of Medicine. A novel way to treat cancer, CAR T-cell

Continue reading

2018-01-31 NEWS

TechCrunch

Engine Biosciences raises $10 million in Southeast Asia’s largest institutional seed round
TechCrunch
Life sciences startups in Asia are getting another boost with the $10 million investment in Engine Biosciences — a biotech company that’s applying machine learning to genomics for drug discovery. With its headquarters in both Singapore and San
With largest transpacific seed round, SF startup aims to rev up drug discoverySan Francisco Business Times

all 8 news articles »

Continue reading

2018-01-31 NEWS

TechCrunch

Engine Biosciences raises $10 million in Southeast Asia’s largest institutional seed round
TechCrunch
Life sciences startups in Asia are getting another boost with the $10 million investment in Engine Biosciences — a biotech company that’s applying machine learning to genomics for drug discovery. With its headquarters in both Singapore and San
With largest transpacific seed round, SF startup aims to rev up drug discoverySan Francisco Business Times

all 8 news articles »

Continue reading

2018-01-31 NEWS

Finance.ua

Корейські вчені розробили ШІ для генного редагування
Finance.ua
Існують також кілька комп’ютерних програм для передбачення наслідків застосування генетичних ножиць, але їх прогнози не відрізняються точністю через брак даних. Команда дослідників з двох вузів Південної Кореї використовувала для вирішення проблеми